GlobeNewswire Inc.··Not SpecifiedAktis Oncology to Present Radioconjugate Pipeline at BofA Securities Conference
Aktis Oncology presents miniprotein radioconjugate platform at BofA Securities conference, advancing AKY-1189 and AKY-2519 across solid tumor indications.
AKTScancer treatmentclinical-stage oncology